Three investment firms with deep health care investing experience are forming a new SPAC that will seek to buy a diagnostics company and take it public, Axios reports.
Venture capital firms ARCH Venture Partners and Section 32 are teaming with Deerfield Management, which invests in both public and private companies, to form the blank-check company. The SPAC already has filed confidentially for its IPO with the SEC. A publicly-available prospectus is expected within the next month or so. Read more.
